It took roughly 3 days to work out a Coronavirus drug deal for Remdesivir, between the company and the EU.
ARD (public TV in Germany, Channel One) briefly covered the story.
Cost? That part of the story is totally lacking.
The deal involving a license for non-Gilead company? That's the way the deal appears. No one says the country of production or how this will work, but it's basically being finalized at this point.
It should be noted....this is not a vaccine, just a drug to take after you have tested positive. In the US, the cost factor is being discussed at $2k for the five-day application.
No comments:
Post a Comment